These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12409167)

  • 1. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment.
    Cuesta MJ; Peralta V; Zarzuela A; Calvo R; García M; Serrano F
    Schizophr Res; 2002 Dec; 58(2-3):263-71. PubMed ID: 12409167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?].
    Dimitri-Valente G; Rigucci S; Manfredi G; Girardi P; Ferracuti S
    Riv Psichiatr; 2012; 47(6):465-78. PubMed ID: 23160107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?
    Tamagni C; Studerus E; Gschwandtner U; Aston J; Borgwardt S; Riecher-Rössler A
    Psychiatry Res; 2013 Dec; 210(2):427-31. PubMed ID: 23880482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of neurological soft signs in first-episode early-onset psychosis.
    Mayoral M; Bombín I; Castro-Fornieles J; González-Pinto A; Otero S; Parellada M; Moreno D; Baeza I; Graell M; Rapado M; Arango C
    J Child Psychol Psychiatry; 2012 Mar; 53(3):323-31. PubMed ID: 22023091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia.
    Das M; Kumari V; Soni W; Ettinger U; Binneman B; Hughes C; Mehrotra R; Sharma T
    Schizophr Bull; 2004; 30(2):241-53. PubMed ID: 15279043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals.
    Mellacqua Z; Eyeson J; Orr KD; Morgan KD; Zanelli J; Lloyd T; Morgan C; Fearon P; Hutchinson G; Doody GA; Chan RC; Harrison G; Jones PB; Murray RM; Reichenberg A; Dazzan P
    Schizophr Res; 2012 Dec; 142(1-3):159-64. PubMed ID: 23092940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No sex differences in neuropsychological performance in first episode psychosis patients.
    Ayesa-Arriola R; Rodriguez-Sanchez JM; Gomez-Ruiz E; Roiz-Santiáñez R; Reeves LL; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():149-54. PubMed ID: 24075821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
    Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.
    Brewer WJ; Francey SM; Wood SJ; Jackson HJ; Pantelis C; Phillips LJ; Yung AR; Anderson VA; McGorry PD
    Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings.
    Yazici AH; Demir B; Yazici KM; Göğüş A
    Schizophr Res; 2002 Dec; 58(2-3):241-6. PubMed ID: 12409164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive insight in non-psychiatric individuals and individuals with psychosis: an examination using the Beck Cognitive Insight Scale.
    Martin JM; Warman DM; Lysaker PH
    Schizophr Res; 2010 Aug; 121(1-3):39-45. PubMed ID: 20399611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups.
    Zabala A; Rapado M; Arango C; Robles O; de la Serna E; González C; Rodríguez-Sánchez JM; Andrés P; Mayoral M; Bombín I
    Eur Arch Psychiatry Clin Neurosci; 2010 Apr; 260(3):225-33. PubMed ID: 19768481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor abnormalities and cognitive impairment in first-episode psychosis patients, their unaffected siblings and healthy controls.
    Cuesta MJ; Moreno-Izco L; Ribeiro M; López-Ilundain JM; Lecumberri P; Cabada T; Lorente-Omeñaca R; Sánchez-Torres AM; Gómez MS; Peralta V
    Schizophr Res; 2018 Oct; 200():50-55. PubMed ID: 29097000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of neurological soft signs and neurocognitive performance in first episode psychosis.
    Arabzadeh S; Amini H; Tehrani-Doost M; Sharifi V; Noroozian M; Rahiminejad F
    Psychiatry Res; 2014 Dec; 220(1-2):81-8. PubMed ID: 25110310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.